APP and Alzheimer disease: CRMP2 hyperphosphorylation, increased mitochondrial fragmentation, and reduced mitochondrial traffic were reported in different AD mouse models, including APP/PS1 mice [8,10,32,42,74], suggesting a link between the CRMP2 phosphorylation state and abnormalities in mitochondrial motility and morphology in AD.